Recent EVO News
- Evotec Appoints Dr. Ingrid Müller as Chief Operating Officer • ACCESS Newswire • 04/15/2026 05:50:00 AM
- Evotec Nominates Dieter Weinand as Supervisory Board Chairman • ACCESS Newswire • 04/07/2026 07:00:00 AM
- Evotec SE to Announce Fourth Quarter and Full-Year 2025 Results on April 8, 2026 • ACCESS Newswire • 04/01/2026 09:35:00 AM
- Evotec Appoints Dr. Ashiq H. Khan as Chief Commercial Officer • ACCESS Newswire • 04/01/2026 05:50:00 AM
- Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership • Edgar (US Regulatory) • 03/31/2026 12:29:44 AM
- Just - Evotec Biologics Enters Project Agreement with BARDA to Optimize Biomanufacturing of Antibodies Against Ebola and Related Viruses • ACCESS Newswire • 03/23/2026 07:10:00 AM
- Evotec Receives $10 M Milestone from Bristol Myers Squibb Protein Degradation Collaboration for Clinical Study Initiation • ACCESS Newswire • 03/19/2026 06:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/10/2026 10:00:54 AM
- Evotec jumps 8% after Berenberg starts coverage with “buy” on partner upside • IH Market News • 02/03/2026 04:18:15 PM
- Just - Evotec Biologics Receives Grant for AI-Driven Optimization of Monoclonal Antibody Developability for Affordable Access • ACCESS Newswire • 01/08/2026 06:50:00 AM
- Evotec Appoints Dr. Sarah Fakih as EVP, Head of Global Communications and Investor Relations • ACCESS Newswire • 01/02/2026 05:30:00 AM
- Evotec Closes Sale of Just - Evotec Biologics' Toulouse Site to Sandoz • ACCESS Newswire • 12/08/2025 06:20:00 AM
- Evotec-Partner Bayer Starts Phase 2 Study for Treatment of Patients with Alport Syndrome • ACCESS Newswire • 12/04/2025 07:50:00 AM
- Evotec Receives Milestone Payment from Bristol Myers Squibb Following IND Acceptance in Strategic Protein Degradation Partnership • ACCESS Newswire • 11/12/2025 07:00:00 AM
- Evotec Shares Drop Over 9% as Weakness in Drug Discovery Drags Nine-Month Results • IH Market News • 11/05/2025 11:37:25 AM
- Evotec SE Reports 9M 2025 Results: Continued Strong Execution on Strategic Priorities • ACCESS Newswire • 11/05/2025 07:00:00 AM
- In A Landmark Industry Transaction, Evotec Signs Agreement With Sandoz, Resulting In Payments Potentially Over US $650 M Plus Royalties • ACCESS Newswire • 11/04/2025 09:30:00 PM
- Evotec SE to Announce Results for The First Nine Months 2025 on 05 November 2025 • ACCESS Newswire • 10/29/2025 09:10:00 AM
- Evotec Announces Progress in Preclinical Neuroscience Partnership with Bristol Myers Squibb • ACCESS Newswire • 10/27/2025 06:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/30/2025 10:03:50 AM
- Evotec shares drop sharply after lowering 2025 revenue forecast • IH Market News • 07/21/2025 01:02:30 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/03/2025 04:10:46 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/06/2025 10:00:17 AM
